HilleVax Quote - HLVX

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

1.8017

Bid

1.77

Ask

1.94

Volume

119,559

1.81 Day's Range 1.88

1.55 52 Week Range 20.22

Market Cap

89.736M

Previous Close

1.83

Open

1.845

Last Trade

112

1.8017

(formt)

Last Trade Time

Financial Volume

US$ 221,307

VWAP

1.851

Average Volume (3m)

263,344

Shares Outstanding

49,806,070

Dividend Yield

PE Ratio

-0.75

Earnings Per Share (EPS)

-2.48

Revenue

Net Profit

-123.57M

HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norov... HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.hillevax.com

Headquarters

Wilmington, Delaware, USA

Founded

HilleVax Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker HLVX. The last closing price for HilleVax was US$1.83. Over the last year, HilleVax shares have traded in a share price range of US$ 1.55 to US$ 20.22.

HilleVax currently has 49,806,070 shares outstanding. The market capitalization of HilleVax is US$91.15 million. HilleVax has a price to earnings ratio (PE ratio) of -0.75.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.1083	-5.67015706806	1.91	1.94	1.67	267729	1.78624453	CS
4	-0.1283	-6.64766839378	1.93	2.036	1.67	172681	1.87016834	CS
12	-0.0283	-1.54644808743	1.83	2.15	1.67	263344	1.94600947	CS
26	0.1017	5.98235294118	1.7	2.15	1.64	251039	1.89042331	CS
52	-12.8983	-87.743537415	14.7	20.22	1.55	424073	3.6429833	CS
156	-16.9583	-90.3960554371	18.76	24.42	1.55	215867	7.03163802	CS
260	-16.9583	-90.3960554371	18.76	24.42	1.55	215867	7.03163802	CS

HLVX - Frequently Asked Questions (FAQ)

What is the current HilleVax share price?

The current share price of HilleVax is US$ 1.8017

How many HilleVax shares are in issue?

HilleVax has 49,806,070 shares in issue

What is the market cap of HilleVax?

The market capitalisation of HilleVax is USD 91.15M

What is the 1 year trading range for HilleVax share price?

HilleVax has traded in the range of US$ 1.55 to US$ 20.22 during the past year

What is the PE ratio of HilleVax?

The price to earnings ratio of HilleVax is -0.75

What is the reporting currency for HilleVax?

HilleVax reports financial results in USD

What is the latest annual profit for HilleVax?

The latest annual profit of HilleVax is USD -123.57M

What is the registered address of HilleVax?

The registered address for HilleVax is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the HilleVax website address?

The website address for HilleVax is www.hillevax.com

Which industry sector does HilleVax operate in?

HilleVax operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
JTAIJet AI Inc	US$ 6.02 (133.33%)	101.64M
SRMSRM Entertainment Inc	US$ 0.6999 (95.50%)	248.48M
WRDWeRide Inc	US$ 31.4877 (83.39%)	20.57M
INLFINLIF Limited	US$ 16.27 (80.58%)	7.67M
MBRXMoleculin Biotech Inc	US$ 2.1201 (66.94%)	134.88M
BLACBellevue Life Sciences Acquisition Corporation	US$ 3.08 (-56.31%)	425.19k
BLACUBellevue Life Sciences Acquisition Corporation	US$ 3.36 (-52.68%)	5.21k
CSAICloudastructure Inc	US$ 19.0001 (-49.58%)	1.01M
NEXNNexxen International Ltd	US$ 10.30 (-49.16%)	160.99k
BSLKBolt Projects Holdings Inc	US$ 0.6626 (-46.13%)	13.07M
CNSPCNS Pharmaceuticals Inc	US$ 0.1415 (31.26%)	480.49M
MGOLMGO Global Inc	US$ 0.7176 (-15.08%)	411.17M
SRMSRM Entertainment Inc	US$ 0.6999 (95.50%)	248.48M
INTCIntel Corporation	US$ 23.60 (-2.20%)	225.04M
NVDANVIDIA Corporation	US$ 138.85 (2.63%)	189.56M